BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 24562809)

  • 61. Improved anti-hyperlipidemic activity of Rosuvastatin Calcium via lipid nanoparticles: Pharmacokinetic and pharmacodynamic evaluation.
    Dudhipala N; Veerabrahma K
    Eur J Pharm Biopharm; 2017 Jan; 110():47-57. PubMed ID: 27810472
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Novel resveratrol nanodelivery systems based on lipid nanoparticles to enhance its oral bioavailability.
    Neves AR; Lúcio M; Martins S; Lima JL; Reis S
    Int J Nanomedicine; 2013; 8():177-87. PubMed ID: 23326193
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Enhanced Oral Bioavailability of Felodipine from Solid Lipid Nanoparticles Prepared Through Effervescent Dispersion Technique.
    He Y; Zhan C; Pi C; Zuo Y; Yang S; Hu M; Bai Y; Zhao L; Wei Y
    AAPS PharmSciTech; 2020 Jun; 21(5):170. PubMed ID: 32529303
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Development, Characterization, and Evaluation of SLN-Loaded Thermoresponsive Hydrogel System of Topotecan as Biological Macromolecule for Colorectal Delivery.
    Xing R; Mustapha O; Ali T; Rehman M; Zaidi SS; Baseer A; Batool S; Mukhtiar M; Shafique S; Malik M; Sohail S; Ali Z; Zahid F; Zeb A; Shah F; Yousaf A; Din F
    Biomed Res Int; 2021; 2021():9968602. PubMed ID: 34285920
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Surface-modified solid lipid nanoparticles for oral delivery of docetaxel: enhanced intestinal absorption and lymphatic uptake.
    Cho HJ; Park JW; Yoon IS; Kim DD
    Int J Nanomedicine; 2014; 9():495-504. PubMed ID: 24531717
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Solid lipid nanoparticles (SLNs) to improve oral bioavailability of poorly soluble drugs.
    Hu L; Tang X; Cui F
    J Pharm Pharmacol; 2004 Dec; 56(12):1527-35. PubMed ID: 15563759
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Mannosylated solid lipid nanoparticles as vectors for site-specific delivery of an anti-cancer drug.
    Jain A; Agarwal A; Majumder S; Lariya N; Khaya A; Agrawal H; Majumdar S; Agrawal GP
    J Control Release; 2010 Dec; 148(3):359-67. PubMed ID: 20854859
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Development and in vivo evaluation of an innovative "Hydrochlorothiazide-in Cyclodextrins-in Solid Lipid Nanoparticles" formulation with sustained release and enhanced oral bioavailability for potential hypertension treatment in pediatrics.
    Cirri M; Mennini N; Maestrelli F; Mura P; Ghelardini C; Di Cesare Mannelli L
    Int J Pharm; 2017 Apr; 521(1-2):73-83. PubMed ID: 28229944
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Radiosensitizing effect of curcumin-loaded lipid nanoparticles in breast cancer cells.
    Minafra L; Porcino N; Bravatà V; Gaglio D; Bonanomi M; Amore E; Cammarata FP; Russo G; Militello C; Savoca G; Baglio M; Abbate B; Iacoviello G; Evangelista G; Gilardi MC; Bondì ML; Forte GI
    Sci Rep; 2019 Jul; 9(1):11134. PubMed ID: 31366901
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Amelioration of ketoconazole in lipid nanoparticles for enhanced antifungal activity and bioavailability through oral administration for management of fungal infections.
    Dudhipala N; Ay AA
    Chem Phys Lipids; 2020 Oct; 232():104953. PubMed ID: 32814084
    [TBL] [Abstract][Full Text] [Related]  

  • 71. In vivo pharmacokinetics and biodistribution of resveratrol-loaded solid lipid nanoparticles for brain delivery.
    Jose S; Anju SS; Cinu TA; Aleykutty NA; Thomas S; Souto EB
    Int J Pharm; 2014 Oct; 474(1-2):6-13. PubMed ID: 25102112
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Anti-glioma activity and the mechanism of cellular uptake of asiatic acid-loaded solid lipid nanoparticles.
    Garanti T; Stasik A; Burrow AJ; Alhnan MA; Wan KW
    Int J Pharm; 2016 Mar; 500(1-2):305-15. PubMed ID: 26775062
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Development of Curcumin-Loaded Solid Lipid Nanoparticles Utilizing Glyceryl Monostearate as Single Lipid Using QbD Approach: Characterization and Evaluation of Anticancer Activity Against Human Breast Cancer Cell Line.
    Bhatt H; Rompicharla SVK; Komanduri N; Aashma S; Paradkar S; Ghosh B; Biswas S
    Curr Drug Deliv; 2018; 15(9):1271-1283. PubMed ID: 29732970
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Lipid nanoparticles of zaleplon for improved oral delivery by Box-Behnken design: optimization, in vitro and in vivo evaluation.
    Dudhipala N; Janga KY
    Drug Dev Ind Pharm; 2017 Jul; 43(7):1205-1214. PubMed ID: 28274147
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Alpha-lipoic acid-stearylamine conjugate-based solid lipid nanoparticles for tamoxifen delivery: formulation, optimization, in-vivo pharmacokinetic and hepatotoxicity study.
    Dhaundiyal A; Jena SK; Samal SK; Sonvane B; Chand M; Sangamwar AT
    J Pharm Pharmacol; 2016 Dec; 68(12):1535-1550. PubMed ID: 27709612
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Formulation-optimization of solid lipid nanocarrier system of STAT3 inhibitor to improve its activity in triple negative breast cancer cells.
    Pindiprolu SKSS; Chintamaneni PK; Krishnamurthy PT; Ratna Sree Ganapathineedi K
    Drug Dev Ind Pharm; 2019 Feb; 45(2):304-313. PubMed ID: 30348020
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Methotrexate-loaded SLNs prepared by coacervation technique: in vitro cytotoxicity and in vivo pharmacokinetics and biodistribution.
    Battaglia L; Serpe L; Muntoni E; Zara G; Trotta M; Gallarate M
    Nanomedicine (Lond); 2011 Nov; 6(9):1561-73. PubMed ID: 22011315
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Novel nanostructured enoxaparin sodium-PLGA hybrid carriers overcome tumor multidrug resistance of doxorubicin hydrochloride.
    Wang J; Wu L; Kou L; Xu M; Sun J; Wang Y; Fu Q; Zhang P; He Z
    Int J Pharm; 2016 Nov; 513(1-2):218-226. PubMed ID: 27628785
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Targeted SLNs for management of HIV-1 associated dementia.
    Rai A; Jain A; Jain A; Jain A; Pandey V; Chashoo G; Soni V; Sharma PR
    Drug Dev Ind Pharm; 2015; 41(8):1321-7. PubMed ID: 25113430
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Development, Optimization, and Evaluation of Carvedilol-Loaded Solid Lipid Nanoparticles for Intranasal Drug Delivery.
    Aboud HM; El Komy MH; Ali AA; El Menshawe SF; Abd Elbary A
    AAPS PharmSciTech; 2016 Dec; 17(6):1353-1365. PubMed ID: 26743643
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.